Home » Topics » Briefs » Other news to note

Other news to note
RSS

Cibinetide receives two FDA orphan drug designations

June 16, 2016

Zydus Cadila and Eczacibassi Ilac Pazarlama establish biosimilars strategic collaboration in Turkey

June 16, 2016

Aegerion Pharmaceuticals and QLT enter strategic merger agreement

June 16, 2016

PeptiDream earns milestone for the dosing of first patient in BMS clinical trial

June 16, 2016

Alpine Immune Sciences announces USD 48 million series A financing

June 15, 2016

ContraVir Pharmaceuticals/Ciclofilin Pharmaceuticals merger complete

June 14, 2016

Dr. Reddy's to acquire portfolio of eight ANDAs from Teva

June 13, 2016

Nexus BioPharma announces the completion of merger

June 13, 2016

Merck & Co. signs definitive agreement to acquire Afferent Pharmaceuticals

June 10, 2016

Ultragenyx and Takeda enter partnership to develop and commercialize rare genetic disease therapies

June 9, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...